AI assistant
Sending…
ELI LILLY & Co — Director's Dealing 2025
Nov 11, 2025
29745_dirs_2025-11-10_e8f211e7-61d0-47c5-804b-01ef09239992.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: ELI LILLY & Co (LLY)
CIK: 0000059478
Period of Report: 2025-11-10
Reporting Person: Ricks David A (Director, President, Chair, and CEO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2025-11-10 | Common Stock | G | 24750 | — | Disposed | 515166.167 | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 6685 | Indirect |
| Common Stock | 54117 | Indirect |
| Common Stock | 300 | Indirect |
| Common Stock | 68656 | Indirect |
| Common Stock | 7305.09 | Indirect |
Footnotes
F1: On September 9, 2025, the Reporting Person transferred 6,685 shares of Eli Lilly and Company common stock to a Grantor Retained Annuity Trust, of which the Reporting Person is the trustee.
F2: The Reporting Person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.
More from ELI LILLY & Co
Regulatory Filings
2026
May 20
Regulatory Filings
2026
May 11
Regulatory Filings
2026
May 8
Regulatory Filings
2026
May 7
Regulatory Filings
2026
May 6
Regulatory Filings
2026
May 6
Major Shareholding Notification
2026
May 1
Interim / Quarterly Report
2026
Apr 30
Regulatory Filings
2026
Apr 30
Regulatory Filings
2026
Apr 29